Therefore, the retention of RIF1 Exon 31 in this tumour type (Figure 2B) contrasts with its behaviour in the receptor-positive breast cancers, where it tends to be excluded along with other Cancer-Altered Short exons. This evidence concerns the gene RIF1 and breast cancer.